Mode
Text Size
Log in / Sign up

Meta-analysis links TNF pathway proteins to ischemic stroke risk and recurrence

Meta-analysis links TNF pathway proteins to ischemic stroke risk and recurrence
Photo by Giovanni Crisalfi / Unsplash
Key Takeaway
Consider that observational associations between TNF pathway proteins and stroke risk do not prove causation.

This is a meta-analysis of individual participant data from four prospective ischemic stroke cohorts and a population-based UK Biobank analysis. The scope was to evaluate associations between circulating TNF-superfamily proteins and ischemic stroke outcomes. In the UK Biobank (n=47,529), higher TNF pathway proteins were independently associated with incident stroke after multivariable adjustment. Hazard ratios per SD increase were 1.14 for TNF (95% CI 1.07–1.20), 1.22 for TNFR1 (95% CI 1.14–1.31), and 1.15 for TNFR2 (95% CI 1.09–1.21). In the IPD meta-analysis (n=2,180; 6793 person-years), TNF-alpha was associated with recurrent stroke (RR 1.50, 95% CI 1.14–1.98) and MACE (RR 1.54, 95% CI 1.18–2.02; 537 MACE events). Spatial transcriptomics of carotid plaque showed TNF detection increased from media to fibrous cap (OR 2.32 vs media, 95% CI 1.94–2.78; p<0.001). The authors note limitations including the observational design, which cannot establish causation, the IPD meta-analysis being limited to four cohorts, and preclinical plaque data not linked to clinical outcomes. Practice relevance is restrained; the data support evaluation of TNF-targeted therapies for stroke prevention but require clinical trial evidence.

Study Details

Study typeMeta analysis
Sample sizen = 2,180
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Background Inflammation is an emerging target for stroke prevention, but additional therapeutic candidates are needed. Experimental and observational studies implicate tumor necrosis factor (TNF) in atherosclerotic plaque progression and cardiovascular events. We integrated plasma proteomics from population-based studies and prospective stroke cohorts with single-cell and spatial transcriptomic profiling of human atherosclerotic plaque to investigate TNF signaling in stroke pathogenesis. Methods We assessed associations between 34 TNF-superfamily proteins (Olink Explore) and incident ischemic stroke among 47,529 UK Biobank participants without cardiovascular disease. We performed an individual-participant data (IPD) meta-analysis of four prospective cohorts with ischemic stroke (n=2,180) to examine associations between TNF-? and recurrent vascular events. We characterised plaque-level TNF biology using single-cell RNA sequencing of 259,116 cells (62 donors) and Xenium spatial transcriptomics (12 donors) with human carotid plaques. Results In UK Biobank, higher circulating TNF pathway proteins were independently associated with incident stroke after multivariable adjustment, including TNF, TNFR1, and TNFR2 (Hazard Ratio [HR] per SD increase, 1.14, [95% CI 1.07?1.20], 1.22, [1.14?1.31], and 1.15 [1.09?1.21], respectively. An additional 15 TNF superfamily members were also associated with incident stroke. In the IPD analysis of stroke cohorts, TNF-? was associated with recurrent stroke (risk ratio [RR] 1.50, 95% CI 1.14-1.98; top vs. bottom third of TNF-?) and MACE (RR 1.54, 1.18-2.02) after adjustment for cardiovascular risk factors and secondary prevention medications (537 MACE events, 6793 person-years follow up). In single-cell RNA plaque sequencing, TNF and TNF pathway genes were broadly expressed across immune cell populations. In spatial transcriptomics, TNF detection increased progressively from media to fibrous cap (Odds Ratio 2.32 vs media, 95% CI 1.94?2.78; p<0.001). At the fibrous cap, CD8+ effector T cells demonstrated 4.1-fold enrichment for TNF expression despite comprising only 3% of fibrous cap cells. Conclusions TNF signaling is independently associated with incident ischemic stroke and recurrent MACE after stroke. TNF is enriched in human carotid plaque at the fibrous cap, in macrophages and CD8+ effector T cells. These results support evaluation of TNF-targeted therapies for stroke prevention.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.